1 study found for:    12644542 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
Conditions: Ovarian Neoplasm;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Drug: Bevacizumab;   Drug: BAY 43-9006

Indicates status has not been verified in more than two years